Equanimity Investments’ Post

👀 Are you looking to boost your practice revenue and provide more comprehensive care to your patients? Say hello to MUSTEC! 🌟 Introducing the Falck Multifunction device – your first step in adding vascular testing. 🔍 Adding vascular testing to your practice is a game-changer. It not only expands your services but also enables early detection of various vascular conditions, giving a clearer view of your patient's health. 👩⚕️ With the Falck device, assessing at-risk patients is a breeze. Its multifunction capabilities swiftly identify potential vascular issues based on science, not opinion. 💡 For doctors treating glaucoma patients, the Falck device measures Ocular Perfusion Pressure (OPP), crucial for effective glaucoma management. 💼 Join several satisfied clients who've seamlessly integrated this solution with MUSTEC Testing service. Whether you're aiming for revenue growth or expanding services, we've got you covered. 📲 Click the link below to schedule a chat and learn how MUSTEC can elevate your practice. Let's make a difference together! https://lnkd.in/ezh6vvDi James@mustecs.com #optometrist #ophthalmologist

🌟 Big news in MedTech! 🌟 Oragenics just leaped forward with a game-changer for concussion treatment! 💡🧠 Their latest innovation? An automated intranasal device delivering ONP-002 right to the brain. Concussed and can't follow instructions? This device is your new ally in the acute phase of injury. 🚑 This is HUGE for the 69 million people facing concussions each year — from sports, accidents, to falls. 🏈🚗 Especially when immediate treatment can make all the difference in recovery. 👩⚕️ As a MedTech recruiter and a nurse, passionate about sports safety, I'm thrilled to see such advancements. Can't wait to see how Oragenics' Phase II trials redefine recovery paths for concussed patients. 🌈 Stay tuned, and let's keep pushing for innovations that enhance patient care and outcomes! 🌟 https://lnkd.in/ezM7B7Af #MedTechInnovation #PatientCare #ConcussionTreatment FloodGate Medical

4DMedical (ASX: 4DX), a global medical technology business specialising in respiratory imaging, has entered a commercial deal with leading Western Australian diagnostic imagining provider, Perth Radiological Clinic, to deliver its XV Technology enabled ventilation reports. 🩻 The agreement will see 4DMedical provide its innovative ventilation reports across 16 clinics operated by Perth Radiological Clinic (PRC) 🩺 The new partnership represents an important milestone in 4DMedical’s Australian expansion strategy 🧬 Builds on two recent commercial wins in the US with Imaging Partners of Orange County and UC San Diego Health “We are delighted to partner with PRC, a leader in diagnostic imaging in Western Australia. This collaboration underscores the value and demand for XV Technology in enhancing respiratory diagnostics.” – Andreas Fouras, 4DMedical Managing Director and Founder ASX announcement ⚡ https://lnkd.in/gT4w7H2V

Let's celebrate World Kidney Day! 🌍 Today, on World Kidney Day, we are reminded of the crucial role kidneys play in our overall health and the importance of early detection and care for kidney-related issues. 🔍 Why does Kinepict stand out? Kinepict's unique Digital Variance Angiography (DVA) technology enables clinicians to select the optimal contrast rate and type, ensuring unparalleled clarity in imaging results. This is particularly important for patients with weak or insufficient kidney function, as it allows for appropriate imaging with contrast dilution. Thus, the kidneys are less burdened during the procedure. 🛡️ Patient-centered care We are aware of the importance of patient safety, especially for those with insufficient kidneys. Kinepict's adjustable contrast rate feature ensures that patients receive the care they need, tailored to their specific health condition, minimizing the risk of contrast-induced nephropathy. 👥 Join our mission On this World Kidney Day, let's embrace the advancements in medical technology that allow for better, safer, and more patient-centered care. 💡 Interested in learning more about how Kinepict is pioneering in contrast agent management? Visit our website or contact us directly. Let's take a step forward in the innovation of patient care together. https://kinepict.com/ #worldkidneyday #kinepict #kidneyhealth #innovation #healthcaretechnology #patientcare

Don't forget to pass by the 𝐄𝐕𝐄𝐒 𝐒𝐦𝐚𝐫𝐭 𝐕𝐢𝐥𝐥𝐚𝐠𝐞 and learn about all the offers and advancements offered by the 𝐄𝐠𝐲𝐩𝐭𝐢𝐚𝐧 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 𝐨𝐟 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐚𝐧𝐝 𝐄𝐧𝐝𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐒𝐮𝐫𝐠𝐞𝐫𝐲! #VascularNews #EndovascularCare #VascularHealth #MedicalInnovation #HealthUpdates #EVN #VascularAdvancements #MedicalNews #HealthcareInnovation #VascularCommunity #EndovascularUpdates #VascularInsights #MedicalResearch #HealthcareProfessionals #EVES2024

Are you looking to boost your practice revenue and provide more comprehensive care to your patients? Say hello to MUSTEC! Introducing the Falck Multifunction device – your first step in adding vascular testing. Adding vascular testing to your practice is a game-changer. It not only expands your services but also enables early detection of various vascular conditions, giving a clearer view of your patient's health. With the Falck device, assessing at-risk patients is a breeze. Its multifunction capabilities swiftly identify potential vascular issues based on science, not opinion. For doctors treating glaucoma patients, the Falck device measures Ocular Perfusion Pressure (OPP), crucial for effective glaucoma management. Join several satisfied clients who've seamlessly integrated this solution with MUSTEC Testing service. Whether you're aiming for revenue growth or expanding services, we've got you covered. Click the link below to schedule a chat and learn how MUSTEC can elevate your practice. Let's make a difference together! https://lnkd.in/ezh6vvDi James@mustecs.com #optometrist #ophthalmologist

Introducing the AccuRead - Electrocardiograph, where precision meets innovation in cardiac diagnostics. Designed to deliver unparalleled accuracy and reliability, it's more than just a machine – it's a lifeline for patients and healthcare professionals alike. Keep your finger on the pulse of medical advancement. For more information and inquiries about the groundbreaking AccuBreath ventilator, reach out to us at +62 852-3036-3603 (Eki) #AccuRead #Electrocardiograph #CardiacCare #MedicalInnovation #HealthTech #alkes #AKD #TKDN #MedTech #alatkesehatan

SkyQuest's Innovation Matrix of the 𝗦𝗽𝗶𝗿𝗼𝗺𝗲𝘁𝗲𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 highlights the key players and their impactful innovations shaping the respiratory diagnostics landscape. Baxter International Inc., Vyaire Medical Inc., and Teleflex Inc. are at the forefront, driving advancements in spirometry technology. Baxter International Inc. leads with its advanced spirometry devices, renowned for their accuracy and reliability in respiratory care. Their focus on integrating cutting-edge technology ensures precise diagnostics and enhances patient outcomes. Vyaire Medical Inc. excels with its state-of-the-art spirometers, designed for real-time data insights and ease of use. Their commitment to innovation and quality supports healthcare providers in delivering superior pulmonary function testing. Teleflex brings to market innovative solutions that optimize respiratory diagnostics. Their focus on high-performance devices and recent collaborations, like the integration with Clario, underscore their role in advancing spirometry technology. Together, these industry leaders are setting new benchmarks in spirometry, advancing the field with their groundbreaking technologies and contributions. Explore our comprehensive report on the Spirometer Market to discover how these innovations are shaping the future of respiratory diagnostics. https://lnkd.in/ebBEFmQZ #MedicalInnovation #HealthcareTechnology #MarketResearch #SkyQuest

As September comes to a close, I find myself reflecting on the incredible journey of innovation and growth we've had at iRhythm! In September of last year, we launched the next-generation Zio® monitor, our smallest, lightest, and thinnest cardiac monitor yet, taking another leap forward in cardiac care. It was an exciting moment, as we committed to delivering better outcomes and experiences for patients with arrhythmias. Fast forward to September 2024, and the progress we've made since then has been nothing short of remarkable: ✅ We’ve expanded the launch of Zio monitor to 4 additional countries, including Austria, the Netherlands, Switzerland, and Spain, bringing our cutting-edge cardiac arrhythmia monitoring service to more patients around the world. ✅ Over 1 million patients have worn Zio monitor since its launch in 2023, and our real-world evidence has demonstrated longer wear duration and analyzable time compared to the prior generation Zio® XT device. This data, presented at HRX 2024, reaffirms our mission to deliver high-quality, reliable, and transformative care to those who need it most. ✅ We've also achieved regulatory approval in Japan for Zio monitor, a significant milestone that marks the first product to deliver arrhythmia monitoring services utilizing artificial intelligence in this region. This opens the door to the second largest healthcare market and even more patients benefiting from the convenience and accuracy of our products. It's inspiring to see the impact we're making and the strides we’re taking in cardiac care worldwide. Thank you to the incredible team at iRhythm, both current and past, and our partners who have made this possible. Looking forward to continuing this journey and shaping the future of digital health! #innovation #digitalhealth #cardiaccare #ZioMonitor #leadership #healthcaretechnology #globalexpansion